Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00174187
Status:
TERMINATED
Last Update Posted:
2012-12-04
First Post:
2005-09-09
Brief Title:
Treatment With Recombinant Human Growth Hormone GH in Children With Short Stature Secondary to a Long Term Corticoid Therapy
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Treatment With Recombinant Human Growth Hormone Genotonorm Registered in Children With Short Stature Secondary to a Long Term Corticoid Therapy A Study of Efficacy and Safety
Status:
TERMINATED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
See termination reason in detailed description
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the effect of a long-term treatment by Genotonorm on linear growth in children with short stature receiving steroid therapy
To assess the effect of a long term treatment with Genotonorm on bone mineralisation
To assess the effect of a long term treatment with Genotonorm on body composition
To assess the effect of a long term treatment with Genotonorm on bone mineralisation
To assess the effect of a long term treatment with Genotonorm on body composition
Detailed Description:
This trial terminated on 10-Jun-2011 due to prolonged issues with drug accountability and data collection discrepancies The decision to terminate was not based on any safety concerns
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A6281016 | None | None | None |